|
Office of the Dean for Research
Contact Us
About Us
Available Technologies
Industry & Entrepreneurs
Faculty & Researchers
News & Events
Contact Us
Search Results - yigong+shi
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Structural, Biochemical, and Functional Analyses of CED-9 Recognition by the Proapoptotic Protein EGL-1
Apoptosis or programmed cell death is an essential process in the development and homeostasis of all multi-cellular organisms such as humans. Suppression of programmed cell death is a contributing reason for a range of human diseases such as cancer. Thus finding a strategy to specifically down-regulate the functions of Bcl-2 and Bcl-xL is...
Published: 2/24/2025
|
Inventor(s):
Yigong Shi
Keywords(s):
Category(s):
Biotechnology/Pharmaceuticals
Compositions and Methods for Regulating Intramembrane Proteases
Princeton University Invention # 07-2348 Intramembrane proteolysis is a widely conserved regulatory mechanism in species ranging from bacteria to humans. The first description of intramembrane proteolysis came from the investigation of cholesterol homeostasis, where the ER membrane-bound transcriptional factor SREBP must be cleaved by an...
Published: 2/24/2025
|
Inventor(s):
Yigong Shi
,
Nieng Yan
Keywords(s):
Category(s):
Biotechnology/Pharmaceuticals
Method of Screening compounds that Antagonize HAUSP
Princeton University Invention # 2174 Cancer is one of the most debilitating diseases affecting mankind. More than 600 thousand patients die of cancer in the United States. Oncogenesis is inhibited by the tumor suppressor genes and accelerated by oncogenes. p53 is one of the most important tumor suppressor proteins and is inactivated in nearly...
Published: 3/30/2022
|
Inventor(s):
Yigong Shi
Keywords(s):
Category(s):
Biotechnology/Pharmaceuticals
Soluble, Functional Apoptotic Protease-Activating Factor-1 Fragments
Princeton University Invention # 05-2166 Apoptosis or programmed cell death is an essential process in the development and homeostasis of humans. Abnormal inhibition of apoptosis is a hallmark of cancer and autoimmune diseases, whereas excessive activation of cell death is implicated in neuro-degenerative disorders such as Alzheimer¿s...
Published: 3/30/2022
|
Inventor(s):
Yigong Shi
Keywords(s):
Category(s):
Biotechnology/Pharmaceuticals